LABD Stock Summary and Trading Ideas (Direxion Daily S&P Biotech Bear 3X | ARCA:LABD)

The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.

Direxion Daily S&P Biotech Bear 3X trades on the ARCA stock market under the symbol LABD.

As of May 7, 2024, LABD stock price climbed to $8.16 with 13,808,603 million shares trading.

LABD has a beta of -4.66, meaning it tends to be less sensitive to market movements. LABD has a correlation of 0.42 to the broad based SPY ETF.

LABD has a market cap of $92.75 million. This is considered a Micro Cap stock.

In the last 3 years, LABD stock traded as high as $85.28 and as low as $5.72.

LABD has underperformed the market in the last year with a price return of -37.0% while the SPY ETF gained +27.0%. LABD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.7% and -21.5%, respectively, while the SPY returned +5.0% and +3.5%, respectively.

LABD support price is $7.65 and resistance is $8.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABD stock will trade within this expected range on the day.